中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
心理研究所 [2]
上海药物研究所 [1]
过程工程研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2022 [2]
2021 [1]
2012 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naive First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
期刊论文
OAI收割
ANTIOXIDANTS, 2022, 卷号: 11, 期号: 4, 页码: 8
作者:
Wang, Keqiang
;
Xiu, Meihong
;
Su, Xiuru
;
Wu, Fengchun
;
Zhang, Xiangyang
  |  
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2022/05/16
schizophrenia
antioxidant protection
therapeutic response
antipsychotics
F-18-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axis
期刊论文
OAI收割
THERANOSTICS, 2022, 卷号: 12, 期号: 14, 页码: 6395-6408
作者:
Jiang, Yuchen
;
Zeng, Qinghe
;
Jiang, Qinghui
;
Peng, Xia
;
Gao, Jing
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2022/12/13
F-18-FDG
FGFR
Therapeutic Response
PET/CT
mTOR/HK2
Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study
期刊论文
OAI收割
PHARMACOPSYCHIATRY, 2021, 卷号: 54, 期号: 02, 页码: 68-74
作者:
Shi, Hui
;
Guan, Xiao Ni
;
Liu, Dian Ying
;
Zhu, Lin
;
Wu, Zhi Wei
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/03/29
schizophrenia
sex difference
weight gain
therapeutic response
body mass index
The orchestration of cellular and humoral responses is facilitated by divergent intracellular antigen trafficking in nanoparticle-based therapeutic vaccine
期刊论文
OAI收割
PHARMACOLOGICAL RESEARCH, 2012, 卷号: 65, 期号: 2, 页码: 189-197
作者:
Yue, Hua
;
Wei, Wei
;
Fan, Bei
;
Yue, Zhanguo
;
Wang, Lianyan
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2013/10/23
Cellular immune response
Humoral immune response
Intracellular trafficking
Polylactide nanoparticles
Therapeutic vaccine